fashion -WSS

fashion

author：leisure time 2025-09-29 22:49:47 - browse：54879

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： MultiPlan and major insurers sued for alleged medical price

WSS

Congress: Prevent baby formula shortages by passing a new bill

Getting Alzheimer's drug Leqembi to patients can be a challenge

FTC falls short on scrutinizing hospital mergers, study says

MultiPlan and major insurers sued for alleged medical price

Q&A: Jennifer Adair on making gene therapy available globally

The Bio Revolution is changing business and society

entertainment

fashion

leisure time

Peter Hotez and the public health issue of online harassment

Bird flu makes raw milk dangerous to consume, mouse study finds

United colonoscopy coverage change 'may cost lives,' doctors say

MassMutual is introducing free genetic testing for members

United colonoscopy coverage change 'may cost lives,' doctors say

H5N1 bird flu found in pasteurized milk: what we know

Heart attack and stroke risk calculators need revising

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

23andMe had bad news about my health. I wish a person had delivered it

Close Medicare's dangerous gaps in addiction treatment coverage

hotspot

Some medical students still think black patients feel less pain

Bird flu in milk supply is likely coming from asymptomatic cows

Cue Health's Covid

Congress: Prevent baby formula shortages by passing a new bill

Beyond aggravation: Constipation is an American epidemic

Cancer researcher Catriona Jamieson is sending tumors into space

entertainment

focus

hotspot

focus